Alcon (ALC)
NYSE:ALC
Want to see ALC full AI Analyst Report?
ALC Stock Chart & Stats
$81.32
-$0.68(-0.81%)
At close: 4:00 PM EST
$81.32
-$0.68(-0.81%)
Day’s Range― - ―
52-Week Range$61.84 - $92.55
Previous Close$87.56
Volume942.02K
Average Volume (3M)2.03M
Market Cap
$33.66B
Enterprise Value$36.81B
Total Cash (Recent Filing)$1.66B
Total Debt (Recent Filing)$5.25B
Price to Earnings (P/E)48.9
Beta0.75
Next Earnings
Aug 10, 2026EPS Estimate
0.76Next Dividend Ex-DateN/A
Dividend Yield0.41%
Share Statistics
EPS (TTM)1.65
Shares Outstanding499,700,000
10 Day Avg. Volume3,163,482
30 Day Avg. Volume2,025,523
Financial Highlights & Ratios
PEG Ratio39.50
Price to Book (P/B)1.79
Price to Sales (P/S)3.61
P/FCF Ratio21.75
Enterprise Value/Market Cap1.09
Enterprise Value/Revenue3.47
Enterprise Value/Gross Profit6.28
Enterprise Value/Ebitda18.64
Forecast
1Y Price Target
$91.57Price Target Upside12.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering16
EPS Forecast (FY)3.43
Revenue Forecast (FY)$11.00B
Bulls Say, Bears Say
Bulls Say
OTC Product DemandExtended allergy seasons could increase demand for Pataday, boosting Alcon's ocular health revenue and supporting overall sales growth.
Prescription Dry-eye Therapy UptakeTRYPTYR's novel mechanism and rapid effect may capture meaningful patient share in dry eye treatment, creating a new revenue stream if commercial uptake proves strong.
Surgical Equipment Upgrade CycleA forthcoming upgrade cycle for surgical systems, supported by a large installed base, can drive higher equipment sales and increase recurring consumables demand.
Bears Say
Premium Intraocular Lens CompetitionRising competition and a likely challenger lens could erode Alcon's premium intraocular lens market share and put pressure on pricing in key markets.
UNITY System Adoption And CostHigher cost of UNITY systems and limited efficiency gains for typical cases may discourage adoption by cost-conscious facilities, limiting equipment and consumables growth.
Valuation And Execution RiskA valuation premium combined with ambitious guidance and muted recent execution increases downside risk if margin improvements and growth drivers do not materialize.
Alcon News
ALC FAQ
What was Alcon’s price range in the past 12 months?
Alcon lowest stock price was $61.84 and its highest was $92.55 in the past 12 months.
What is Alcon’s market cap?
Alcon’s market cap is $33.66B.
When is Alcon’s upcoming earnings report date?
Alcon’s upcoming earnings report date is Aug 10, 2026 which is in 80 days.
How were Alcon’s earnings last quarter?
Alcon released its earnings results on May 05, 2026. The company reported $0.842 earnings per share for the quarter, beating the consensus estimate of $0.809 by $0.033.
Is Alcon overvalued?
According to Wall Street analysts Alcon’s price is currently Undervalued.
Does Alcon pay dividends?
Alcon pays a Annually dividend of $0.333 which represents an annual dividend yield of 0.41%. See more information on Alcon dividends here
What is Alcon’s EPS estimate?
Alcon’s EPS estimate is 0.76.
How many shares outstanding does Alcon have?
Alcon has 499,700,000 shares outstanding.
What happened to Alcon’s price movement after its last earnings report?
Alcon reported an EPS of $0.842 in its last earnings report, beating expectations of $0.809. Following the earnings report the stock price went down -11.717%.
Which hedge fund is a major shareholder of Alcon?
Currently, no hedge funds are holding shares in ALC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Alcon Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$91.57 (12.61% Upside)
$91.57 (12.61% Upside)
Blogger Sentiment
Bullish
ALC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 872.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.0%
Last 30 Days ▲ 0.7%
Last 30 Days ▲ 0.7%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-23.23%
12-Months-Change
Fundamentals
Return on Equity
3.69%
Trailing 12-Months
Asset Growth
1.97%
Trailing 12-Months
Company Description
Alcon
Alcon Inc., an eye care company, researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for use in surgical procedures. Its cataract products include centurion vision system, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantables products, including AcrySof IQ IOLs products include monofocal IOLs and advanced technology IOLs under the PanOptix and ReSTOR brands for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers under the TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux brands. The company was formerly known as Alcon Universal S.A. and changed the name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.
ALC Company Deck
ALC Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presented a largely constructive picture: solid top-line growth across surgical, vision care and ocular health, strong early adoption and share gains from new product launches (Unity, PanOptix Pro, Tryptyr, Total30), a meaningful equipment acceleration and a shareholder-friendly $1.5B repurchase plan. Offsetting this optimism were market headwinds (soft cataract volumes, China weakness), tariff-driven margin pressure, modest operational disruptions (Hydrus supply, Middle East shipping) and near-term margin timing (Q2 SG&A peak). Management maintained full-year guidance (5%–7% sales growth; 70–170 bps core operating margin expansion) and positioned the back half of 2026 for stronger contribution from new products, implying overall confidence in durable growth despite short-term noise.View all ALC earnings summariesALC Stock 12 Month Forecast
Average Price Target
$91.57
▲(12.61% Upside)
Technical Analysis
Ownership Overview
―
Insiders
12.80% Mutual Funds
16.40% Other Institutional Investors
54.65% Public Companies and
Individual Investors